Xampla
Xampla creates plant protein material for commercial use.
Xampla has raised €29M across 4 funding rounds from 11 investors, most recently a Series A round in Sep 2025. Based in Cambridge, UK; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€29M
€29,496,791
Funding rounds
4
Investors
11
distinct backers
Active since
2020-04
latest 2025-09
Funding by year
EUR raised per yearXampla — funding by year — interactive chart.
Data table
| Xampla — funding by year | |
|---|---|
| 2020 | €2.3M |
| 2021 | €6.8M |
| 2024 | €6.4M |
| 2025 | €14M |
Signals
High confidenceRaise-next likelihood66
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood25
base rate 11% (2+ rounds)
- ▲ 4 rounds raised
- ▲ 8y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-04 | Series A | €14M | Amadeus Capital Partners,BGF,existing backers,Horizons Ventures,Matterwave Ventures | View deal → |
| 2024-01-30 | Other | €6.4M | Amadeus Capital Partners,Cambridge Angels,Cambridge Enterprise,CIECH Ventures,Horizon Capital,Martlet Capital | View deal → |
| 2021-01-08 | Seed | €6.8M | — | View deal → |
| 2020-04-29 | Seed | €2.3M | Amadeus Capital Partners,University of Cambridge Enterprise | View deal → |